Serena Williams has come forward about her use of GLP-1 medications to address weight issues following motherhood, hoping to challenge societal stigmas surrounding anti-obesity treatments and promote awareness of their complexities.
Serena Williams Opens Up on Weight-Loss Journey: Shattering Stigmas Around Anti-Obesity Medications

Serena Williams Opens Up on Weight-Loss Journey: Shattering Stigmas Around Anti-Obesity Medications
The tennis legend advocates for transparency to alleviate the shame associated with weight-loss drugs.
In a candid interview on the Today Show, tennis superstar Serena Williams revealed her struggles with weight loss after childbirth, leading her to explore GLP-1 medications used for weight management. The 43-year-old, renowned for her athleticism and record of 23 grand slam titles, disclosed that despite her rigorous training regimens, losing weight became a significant challenge for her post-maternity. Williams, comparing her weight to an “opponent,” explained how she had to resort to different strategies to combat her weight struggles and that many peers had also turned to similar medications for help.
Her choice has prompted a mixed reaction, given that she is now a spokesperson for Ro, a company marketing GLP-1 drugs. Critics have scrutinized the timing of her admission, raising conversations on whether it undermines the dedication and effort required for weight loss. Nevertheless, her honesty sheds light on the emotional and societal pressures women face concerning their body image, potentially paving the way for a broader acceptance of weight-loss medications in public discourse.
Dr. Caleb Luna, a professor at the University of California, acknowledges Williams's revelations as groundbreaking, helping combat stigmas that portray users of weight loss drugs in a negative light. Conversely, he warns that society's focus on appearance remains troubling, overshadowing an athlete's accomplishments due to her body size.
Williams's stance echoes the sentiments of other public figures, including Oprah Winfrey and Kelly Clarkson, who have also embraced GLP-1 medications as part of their weight-loss journeys. While Williams continues to celebrate her successes in training, she emphasizes the need for a balanced approach to health, incorporating diet and exercise alongside medication, despite the complexities and potential side effects associated with such drug therapies.
Experts like Dr. Claire Madigan from Loughborough University stress the difficulties athletes like Williams face in maintaining a healthy weight after retiring from intense sports. They commend Williams for sharing her struggles while also expressing concerns about the potential demotivating implications for ordinary individuals considering such medications.
Williams, undeterred, marked significant progress in her health journey while training for a half marathon, stating, “I am running farther than I ever have.” She continues to advocate for healthy living and seeks to inspire others, dismantling stereotypes tied to weight-loss medications and normalizing open conversation about body image and well-being.